[The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].

The effect of combined treatment was studied in 97 patients with nonseminomatous testicular tumors with regional and distant metastases with regard to the blood serum levels of alpha-fetoprotein and chorionic gonadotropin. The disease stage was found closely correlating with the efficacy of the treatment and the level of tumor markers. Complete remission was observed in 84.

[Treatment of patients with stage I-II non-seminoma germ-cell tumors of the testis].

Stage I--II disease was identified in 71 out of 219 patients with nonseminomatous germ cell tumors of the testis. After orchifuniculectomy, polychemotherapy was given to 30 patients while the rest underwent transperitoneal lymphadenectomy. Long-term survival in the polychemotherapy group was 83.